We report here a comparative analysis of the acute antidepressant actions of derivatives of 3-hydroxypyridine and succinic acid (emoxypine, Reamberin, and Mexidol) developing 30–45 min after single drug doses. The acute antidepressant effects of emoxypine, Reamberin, and Mexidol were assessed from the dynamics of reductions in the duration of “behavioral despair” in rats during 15-min sessions of forced swimming starting 30 min after drug administration. The stimulatory or sedative activities of the study drugs were also assessed, in terms of their influences on behavior in animals in the open field test. All derivatives of 3-hydroxypyridine and succinic acid studied here had acute antidepressant effects. The rate of onset of this effect and the presence of stimulatory or sedative activities depended on the characteristics of the chemical structures of the derivatives of 3-hydroxypyridine and succinic acid. The 3-hydroxypyridine-only derivative (emoxypine) was less active than the succinic acid derivatives (Reamberin and Mexidol) in terms of the rate of onset of the antidepressant effect and had stimulatory actions after single subantidepressant doses. Reamberin and Mexidol had acute antidepressant effects on the background of concomitant sedative effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ya. Buresh, O. Bureshova, and J. P. Houston, Methods and Basic Experiments in Research on the Brain and Behavior, Vysshaya Shkola, Moscow (1991).
I. A. Volchegorskii, I. I. Dolgushin, O. L. Kolesnikov, and V. E. Tseilikman, Experimental Modeling and Laboratory Evaluation of the Body’s Adaptive Reactions, Chelyabinsk State Pedagogical University Pres, Chelyabinsk (2000).
I. A. Volchegorskii and N. V. Mester, “Effects of antioxidants of the 3-hydroxypyridine group on depression in patients with diabetes mellitus,” Klin. Med., 85, No. 2, 40–45 (2007).
I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Antidepressant actions of α-lipoic acid and Reamberin in alloxan diabetes in mice,” Prob. Endokrinol., 55, No. 4, 20–24 (2009).
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, and R. M. Faizullin, “Studies of the antidepressant activity of derivatives of 3-hydroxypyridine and succinic acid in experiments on mice,” Eksperim. Klin. Farmakol., 76, No. 7, 6–10 (2013).
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, and R. M. Faizullin, “The insulin-potentiating and antidepressant actions of derivatives of 3-hydroxypyridine and succinic acid,” Eksperim. Klin. Farmakol., 77, No. 5, 6–9 (2014).
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Experimental studies of the antidepressant action of derivatives of 3-hydroxypyridine and succinic acid,” Zh. Nevrol. Psikhiat., 2, 48–52 (2015).
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Anxiolytic and antidepressant actions of derivatives of 3-hydroxypyridine and succinic acid in alloxan diabetes,” Ros. Fiziol. Zh., 101, No. 3, 258–267 (2015).
I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Antianhedonistic actions of derivatives of 3-hydroxypyridine and succinic acid,” Ros. Fiziol. Zh., 102, No. 11, 1312–1322 (2016).
T. A. Voronina, “Mexidol: spectrum of pharmacological effects,” Zh. Nevrol. Psikhiat., 12, 86–90 (2012).
E. S. Kovaleva, L. L. Prilipko, K. O. Muranov, and V. E. Kagan, “Actions of antioxidants on 3H-serotonin release from rat brain synaptosomes,” Byull. Eksperim. Biol. Med., 96, No. 10, 55–57 (1983).
A. N. Mironov, Handbook for Preclinical Studies of Drugs, Grif i K, Moscow (2012).
V. G. Motin, V. V. Yasnetsov, A. A. Zabozlaev, et al., “An electrophysiological study of the mechanism of action of Mexidol,” Eksperim. Klin. Farmakol., 75, No. 1, 3–7 (2012).
S. B. Seredenin, G. M. Molodavkin, M. V. Voronin, and T. A. Voronina, “Antidepressant action of afobazole in the Porsolt and Nomura tests,” Eksperim. Klin. Farmakol., 72, No. 1, 19–21 (2009).
A. B. Smulevich, Depression in Somatic and Mental Diseases, Medical Information Agency, Moscow (2003).
P. W. Andrews and J. A. Thomson, “The bright side of being blue: depression as an adaptation for analyzing complex problems,” Psychol. Rev., 116, No. 3, 620–654 (2009).
J. J. Buccafusco, Methods of Behavioral Analysis in Neuroscience, CRC Press LLC, London, New York (2009).
Shi Yu Chan, E. Matthews, and P. W. J. Burne, “ON or OFF?: Modulating the N-methyl-D-aspartate receptor in major depression,” Front .Mol. Neuroscience, 9, 169 (2016).
K. E. DeWilde, C. F. Levitch, J. W. Murrough, et al., “The promise of ketamine for treatment-resistant depression: current evidence and future directions,” Ann. N. Y. Acad. Sci., 1345, 47–58 (2015).
E. R. Kloet and M. L. Molendijk, “Coping with the forced swim stressor: Towards understanding an adaptive mechanism,” Neural Plast., 2016, 6503162 (2016).
M. R. Levinstein and B. A. Samuels, “Mechanisms underlying the antidepressant response and treatment resistance,” Front. Behav. Neurosci., 8, 208 (2014).
F. Lopez-Munoz and C. Alamo, “Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today,” Curr. Pharm. Des., 15, No. 14, 1563–1586 (2009).
R. D. Porsolt, G. Anton, N. Blavet, and M. Jalfre, “Behavioural despair in rats: a new model sensitive to antidepressant treatments,” Eur. J. Pharmacol., 47, No. 4, 379–391 (1978).
N. L. Rasgon, H. A. Kenna, K. E. Williams, et al., “Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study,” Sci. World J., 10, 321–328 (2010).
I. J. Shin, S. U. Son, H. Park, et al., “Preclinical evidence of rapid-onset antidepressant-like effect in Radix polygalae extract,” PLoS One, 9, No. 2, e88617 (2014).
D. A. Slattery and J. F. Cryan, “Using the rat forced swim test to assess antidepressant-like activity in rodents,” Nat. Protoc., 7, No. 6, 1009–1014 (2012).
A. C. Wulsin, J. P. Herman, and M. B. Solomon, “Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress,” Psychoneuroendocrinology, 35, No. 7, 1100–1112 (2010).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 103, No. 7, pp. 755–767, July, 2017.
Rights and permissions
About this article
Cite this article
Volchegorskii, I.A., Miroshnichenko, I.Y. & Rassokhina, L.M. Acute Antidepressant Effects of Derivatives of 3-Hydroxypyridine and Succinic Acid in Experiments on Rats. Neurosci Behav Physi 49, 495–501 (2019). https://doi.org/10.1007/s11055-019-00761-9
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-019-00761-9